{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T16:36:53Z","timestamp":1761237413005},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2007,3,8]],"date-time":"2007-03-08T00:00:00Z","timestamp":1173312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,3,8]],"date-time":"2007-03-08T00:00:00Z","timestamp":1173312000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1038\/sj.leu.2404622","type":"journal-article","created":{"date-parts":[[2007,3,8]],"date-time":"2007-03-08T10:20:55Z","timestamp":1173349255000},"page":"1044-1049","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Fludarabine induces apoptosis of human T-cell leukemia virus type 1-infected T cells via inhibition of the nuclear factor-\u03baB signal pathway"],"prefix":"10.1038","volume":"21","author":[{"given":"C","family":"Nishioka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Ikezoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H P","family":"Koeffler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,3,8]]},"reference":[{"key":"BF2404622_CR1","doi-asserted-by":"publisher","first-page":"6476","DOI":"10.1073\/pnas.78.10.6476","volume":"78","author":"Y Hinuma","year":"1981","unstructured":"Hinuma Y, Nagata K, Hanaoka M, Nakai M, Matsumoto T, Kinoshita KI et al. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci USA 1981; 78: 6476\u20136480.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF2404622_CR2","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1073\/pnas.79.6.2031","volume":"79","author":"M Yoshida","year":"1982","unstructured":"Yoshida M, Miyoshi I, Hinuma Y . Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA 1982; 79: 2031\u20132035.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF2404622_CR3","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1097\/00042560-199606010-00012","volume":"12","author":"H Taguchi","year":"1996","unstructured":"Taguchi H, Kinoshita KI, Takatsuki K, Tomonaga M, Araki K, Arima N et al. An intensive chemotherapy of adult T-cell leukemia\/lymphoma: CHOP followed by etoposide, vindesine, ranimustine, and mitoxantrone with granulocyte colony-stimulating factor support. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 12: 182\u2013186.","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"BF2404622_CR4","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1046\/j.1365-2141.2001.02737.x","volume":"113","author":"Y Yamada","year":"2001","unstructured":"Yamada Y, Tomonaga M, Fukuda H, Hanada S, Utsunomiya A, Tara M et al. A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303. Br J Haematol 2001; 113: 375\u2013382.","journal-title":"Br J Haematol"},{"key":"BF2404622_CR5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1182\/blood.V74.1.19.19","volume":"74","author":"MJ Keating","year":"1989","unstructured":"Keating MJ, Kantarjian H, Talpaz M, Redman J, Koller C, Barlogie B et al. Fludarabine: a new agent with major activity against chronic lymphocytic leukemia. Blood 1989; 74: 19\u201325.","journal-title":"Blood"},{"key":"BF2404622_CR6","first-page":"2","volume":"20","author":"W Plunkett","year":"1993","unstructured":"Plunkett W, Gandhi V, Huang P, Robertson LE, Yang LY, Gregoire V et al. Fludarabine: pharmacokinetics, mechanisms of action, and rationales for combination therapies. Semin Oncol 1993; 20: 2\u201312.","journal-title":"Semin Oncol"},{"key":"BF2404622_CR7","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/sj.bmt.1705271","volume":"37","author":"RK Dasgupta","year":"2006","unstructured":"Dasgupta RK, Rule S, Johnson P, Davies J, Burnett A, Poynton C et al. Fludarabine phosphate and melphalan: a reduced intensity conditioning regimen suitable for allogeneic transplantation that maintains the graft versus malignancy effect. Bone Marrow Transplant 2006; 37: 455\u2013461.","journal-title":"Bone Marrow Transplant"},{"key":"BF2404622_CR8","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.ccr.2004.09.003","volume":"6","author":"BB Aggarwal","year":"2004","unstructured":"Aggarwal BB . Nuclear factor-kappaB: the enemy within. Cancer Cell 2004; 6: 203\u2013208.","journal-title":"Cancer Cell"},{"key":"BF2404622_CR9","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/nature02924","volume":"431","author":"E Pikarsky","year":"2004","unstructured":"Pikarsky E, Porat RM, Stein I, Avramovitch R, Amit S, Kasem S et al. NF-kappaB functions as tumor promoter in inflammation associated cancer. Nature 2004; 431: 461\u2013466.","journal-title":"Nature"},{"key":"BF2404622_CR10","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1146\/annurev.immunol.14.1.649","volume":"14","author":"AS Baldwin Jr","year":"1996","unstructured":"Baldwin Jr AS . The NF-\u03baB and I\u03baB proteins: new discoveries and insights. Annu Rev Immunol 1996; 14: 649\u2013683.","journal-title":"Annu Rev Immunol"},{"key":"BF2404622_CR11","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1182\/blood-2002-01-0151","volume":"100","author":"N Mori","year":"2002","unstructured":"Mori N, Yamada Y, Ikeda S, Yamasaki Y, Tsukasaki K, Tanaka Y et al. Bay 11-7082 inhibits transcription factor NF-kappaB and induces apoptosis of HTLV-1-infected T-cell lines and primary adult T-cell leukemia cells. Blood 2002; 100: 1828\u20131834.","journal-title":"Blood"},{"key":"BF2404622_CR12","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/sj.leu.2403400","volume":"18","author":"Y Satou","year":"2004","unstructured":"Satou Y, Nosaka K, Koya Y, Yasunaga JI, Toyokuni S, Matsuoka M . Proteasome inhibitor, bortezomib, potently inhibits the growth of adult T-cell leukemia cells both in vivo and in vitro. Leukemia 2004; 18: 1357\u20131363.","journal-title":"Leukemia"},{"key":"BF2404622_CR13","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1158\/1535-7163.MCT-04-0277","volume":"4","author":"T Ikezoe","year":"2005","unstructured":"Ikezoe T, Yang Y, Bandobashi K, Saito T, Takemoto S, Machida H et al. Oridonin, a diterpenoid purified from Rabdosia rubescens, inhibits the proliferation of cells from lymphoid malignancies in association with blockade of the NF-kappa B signal pathways. Mol Cancer Ther 2005; 4: 578\u2013586.","journal-title":"Mol Cancer Ther"},{"key":"BF2404622_CR14","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/sj.cdd.4401826","volume":"13","author":"AD Schimmer","year":"2006","unstructured":"Schimmer AD, Dalili S, Batey RA, Riedl SJ . Targeting XIAP for the treatment of malignancy. Cell Death Differ 2006; 13: 179\u2013188.","journal-title":"Cell Death Differ"},{"key":"BF2404622_CR15","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1111\/j.1349-7006.2005.00106.x","volume":"96","author":"C Nishioka","year":"2005","unstructured":"Nishioka C, Takemoto S, Kataoka S, Yamanaka S, Moriki T, Shoda M et al. Serum level of soluble CD30 correlates with the aggressiveness of adult T-cell leukemia\/lymphoma. Cancer Sci 2005; 96: 810\u2013815.","journal-title":"Cancer Sci"},{"issue":"Suppl 1","key":"BF2404622_CR16","doi-asserted-by":"publisher","first-page":"S50","DOI":"10.1038\/sj.thj.6200391","volume":"5","author":"SA Johnson","year":"2004","unstructured":"Johnson SA . Use of fludarabine in the treatment of mantle cell lymphoma, Waldenstrom's macroglobulinemia and other uncommon B- and T-cell lymphoid malignancies. Hematol J 2004; 5 (Suppl 1): S50\u2013S61.","journal-title":"Hematol J"},{"key":"BF2404622_CR17","first-page":"4570","volume":"9","author":"JC Pahler","year":"2003","unstructured":"Pahler JC, Ruiz S, Niemer I, Calvert LR, Andreeff M, Keating M et al. Effects of the proteasome inhibitor, bortezomib, on apoptosis in isolated lymphocytes obtained from patients with chronic lymphocytic leukemia. Clin Cancer Res 20031; 9: 4570\u20134577.","journal-title":"Clin Cancer Res"},{"key":"BF2404622_CR18","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.leukres.2003.12.010","volume":"28","author":"TW Kelley","year":"2004","unstructured":"Kelley TW, Alkan S, Srkalovic G, Hsi ED . Treatment of human chronic lymphocytic leukemia cells with the proteasome inhibitor bortezomib promotes apoptosis. Leuk Res 2004; 28: 845\u2013850.","journal-title":"Leuk Res"},{"key":"BF2404622_CR19","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1002\/cncr.22097","volume":"107","author":"S Faderl","year":"2006","unstructured":"Faderl S, Rai K, Gribben J, Byrd JC, Flinn IW, O'brien S et al. Phase II study of single-agent bortezomib for the treatment of patients with fludarabine-refractory B-cell chronic lymphocytic leukemia. Cancer 2006; 107: 916\u2013924.","journal-title":"Cancer"},{"key":"BF2404622_CR20","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/j.1365-2133.2004.05712.x","volume":"150","author":"P Quaglino","year":"2004","unstructured":"Quaglino P, Fierro MT, Rossotto GL, Savoia P, Bernengo MG . Treatment of advanced mycosis fungoides\/Sezary syndrome with fludarabine and potential adjunctive benefit to subsequent extracorporeal photochemotherapy. Br J Dermatol 2004; 150: 327\u2013336.","journal-title":"Br J Dermatol"},{"key":"BF2404622_CR21","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00277-003-0638-9","volume":"82","author":"RS Go","year":"2003","unstructured":"Go RS, Gazelka H, Hogan JD, Wester SM . Subcutaneous panniculitis-like T-cell lymphoma: complete remission with fludarabine. Ann Hematol 2003; 82: 247\u2013250.","journal-title":"Ann Hematol"},{"key":"BF2404622_CR22","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/7445","volume":"5","author":"DA Frank","year":"1999","unstructured":"Frank DA, Mahajan S, Ritz J . Fludarabine-induced immunosuppression is associated with inhibition of STAT1 signaling. Nat Med 1999; 5: 444\u2013447.","journal-title":"Nat Med"},{"key":"BF2404622_CR23","doi-asserted-by":"publisher","first-page":"4948","DOI":"10.4049\/jimmunol.175.8.4948","volume":"175","author":"L Klotz","year":"2005","unstructured":"Klotz L, Schmidt M, Giese T, Sastre M, Knolle P, Klockgether T et al. Proinflammatory stimulation and pioglitazone treatment regulate peroxisome proliferator-activated receptor gamma levels in peripheral blood mononuclear cells from healthy controls and multiple sclerosis patients. J Immunol 2005; 175: 4948\u20134955.","journal-title":"J Immunol"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2404622.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2404622","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2404622.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T02:45:11Z","timestamp":1648781111000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2404622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3,8]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["BF2404622"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2404622","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3,8]]},"assertion":[{"value":"26 August 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2006","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2007","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2007","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}